BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36326384)

  • 1. Nucleolus assessment in invasive breast carcinoma, an objective parameter for histological grading.
    Öztürk SD; Öztürk Ç; Okcu O; Şen B; Bedir R
    Turk J Med Sci; 2022 Aug; 52(4):975-983. PubMed ID: 36326384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term analysis to objectify the tumour grading by means of automated microscopic image analysis of the nucleolar organizer regions (AgNORs) in the case of breast carcinoma.
    Winzer KJ; Bellach J; Hufnagl P
    Diagn Pathol; 2013 Apr; 8():56. PubMed ID: 23566354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of nucleolar assessment in invasive breast cancer.
    Elsharawy KA; Toss MS; Raafat S; Ball G; Green AR; Aleskandarany MA; Dalton LW; Rakha EA
    Histopathology; 2020 Apr; 76(5):671-684. PubMed ID: 31736094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.
    Delahunt B; Sika-Paotonu D; Bethwaite PB; William Jordan T; Magi-Galluzzi C; Zhou M; Samaratunga H; Srigley JR
    Am J Surg Pathol; 2011 Aug; 35(8):1134-9. PubMed ID: 21716085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of proliferative index with various clinicopathologic prognostic parameters in primary breast carcinoma: A study from North India.
    Marwah N; Batra A; Marwah S; Gupta V; Shakya S; Sen R
    J Cancer Res Ther; 2018; 14(3):537-542. PubMed ID: 29893312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic values of grading system for lymph vessel tumor emboli in patients with invasive breast carcinomas of no special type].
    Yue M; Li F; Deng HY; Zhang LL; Liu YP
    Zhonghua Zhong Liu Za Zhi; 2017 Oct; 39(10):754-758. PubMed ID: 29061019
    [No Abstract]   [Full Text] [Related]  

  • 7. Back to Basics: Traditional Nottingham Grade Mitotic Counts Alone are Significant in Predicting Survival in Invasive Breast Carcinoma.
    Chang JM; McCullough AE; Dueck AC; Kosiorek HE; Ocal IT; Lidner TK; Gray RJ; Wasif N; Northfelt DW; Anderson KS; Pockaj BA
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S509-15. PubMed ID: 26001860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleomorphic lobular carcinoma of the breast: is it a prognostically significant pathological subtype independent of histological grade?
    Rakha EA; van Deurzen CH; Paish EC; Macmillan RD; Ellis IO; Lee AH
    Mod Pathol; 2013 Apr; 26(4):496-501. PubMed ID: 23238630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ONEST (Observers Needed to Evaluate Subjective Tests) suggests four or more observers for a reliable assessment of the consistency of histological grading of invasive breast carcinoma: A reproducibility study with a retrospective view on previous studies.
    Cserni B; Bori R; Csörgő E; Oláh-Németh O; Pancsa T; Sejben A; Sejben I; Vörös A; Zombori T; Nyári T; Cserni G
    Pathol Res Pract; 2022 Jan; 229():153718. PubMed ID: 34920295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of silver-stained nucleolar organizer region associated proteins (AgNORs) after wet autoclave pretreatment in breast carcinoma: correlation to tumor stage and long-term survival.
    Ofner D; Bier B; Heinrichs S; Berghorn M; Dünser M; Hagemann HA; Langer D; Böcker W; Schmid KW
    Breast Cancer Res Treat; 1996; 39(2):165-76. PubMed ID: 8872325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic effect of histological tumor grade in node-negative breast cancer patients.
    Schumacher M; Schmoor C; Sauerbrei W; Schauer A; Ummenhofer L; Gatzemeier W; Rauschecker H
    Breast Cancer Res Treat; 1993; 25(3):235-45. PubMed ID: 8369525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.
    Cherbal F; Gaceb H; Mehemmai C; Saiah I; Bakour R; Rouis AO; Boualga K; Benbrahim W; Mahfouf H
    Breast Dis; 2015; 35(2):95-102. PubMed ID: 25736840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The correlation of
    Qu YH; Long N; Ran C; Sun J
    Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic grading of breast carcinoma: a multi-institution study of interobserver variation using virtual microscopy.
    Ginter PS; Idress R; D'Alfonso TM; Fineberg S; Jaffer S; Sattar AK; Chagpar A; Wilson P; Harigopal M
    Mod Pathol; 2021 Apr; 34(4):701-709. PubMed ID: 33077923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.
    Ferguson NL; Bell J; Heidel R; Lee S; Vanmeter S; Duncan L; Munsey B; Panella T; Orucevic A
    Breast J; 2013; 19(1):22-30. PubMed ID: 23240985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Budding is a reliable predictor for death and metastasis in invasive ductal breast cancer and correlates with other prognostic clinicopathological parameters.
    Okcu O; Öztürk Ç; Şen B; Arpa M; Bedir R
    Ann Diagn Pathol; 2021 Oct; 54():151792. PubMed ID: 34293708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study on clinico-pathological assessment of response to neoadjuvant chemotherapy in breast carcinoma.
    Mohapatra M; Sarma YS
    J Cancer Res Ther; 2020; 16(6):1419-1425. PubMed ID: 33342807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mitotically active, cellular tumor stroma and/or inflammatory cells associated with tumor cells may contribute to intermediate or high Oncotype DX Recurrence Scores in low-grade invasive breast carcinomas.
    Acs G; Esposito NN; Kiluk J; Loftus L; Laronga C
    Mod Pathol; 2012 Apr; 25(4):556-66. PubMed ID: 22173289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metaplastic breast carcinomas and their relationship with basal-like phenotype.
    Cakir A; Gönül II; Uluoğlu O
    Turk Patoloji Derg; 2012; 28(2):134-41. PubMed ID: 22627631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of Ki67 and clinicopathological features in breast cancer].
    Wang B; Wang X; Wang J; Xuan L; Wang Z; Wang X; Gao J; Zhang H
    Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):273-5. PubMed ID: 24989913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.